Search filters

List of works by Antonello Veccia

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

scientific article published on 19 March 2019

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study.

scientific article published on 25 October 2014

Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger

scientific article published on 20 April 2015

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer

scientific article

Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program

article

Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.

scientific article published on 5 October 2015

Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone.

scientific article published on 20 April 2017

Management of brain metastases from lung cancer in the era of immunotherapy: a review of the literature

scientific article published on 06 January 2021

Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone.

scientific article published on 15 May 2015

Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era

scientific article published on 26 May 2020

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.

scientific article published on 13 October 2016

Paulina is supported by:

About Paulina

Help